momelotinib
Showing 1 - 9 of 9
Myelofibrosis Trial (Momelotinib)
Available
- Myelofibrosis
- Momelotinib
- (no location specified)
Oct 12, 2022
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +4 more
- Momelotinib
-
Scottsdale, Arizona
- +21 more
Jan 18, 2021
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Active, not recruiting
- Primary Myelofibrosis
- +2 more
- Momelotinib
- +3 more
-
Phoenix, Arizona
- +166 more
Jan 27, 2022
Polycythemia Vera, Essential Thrombocythemia Trial in Worldwide (Momelotinib)
Terminated
- Polycythemia Vera
- Essential Thrombocythemia
- Momelotinib
-
Scottsdale, Arizona
- +14 more
Apr 14, 2020
Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) Trial
Completed
- Primary Myelofibrosis (PMF)
- +2 more
- Momelotinib
- Best Available Therapy (BAT)
-
Los Angeles, California
- +47 more
Apr 1, 2020
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +2 more
- Momelotinib
- +3 more
-
Phoenix, Arizona
- +113 more
Apr 13, 2020
Metastatic Pancreatic Ductal Adenocarcinoma Trial in United States (Momelotinib, Placebo to match momelotinib, Nab-paclitaxel)
Terminated
- Metastatic Pancreatic Ductal Adenocarcinoma
- Momelotinib
- +3 more
-
Los Angeles, California
- +3 more
Jan 31, 2019
Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Canada, United States
Completed
- Primary Myelofibrosis
- +2 more
- Momelotinib
-
Scottsdale, Arizona
- +5 more
Jan 31, 2019
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Australia,
Completed
- Primary Myelofibrosis
- +2 more
- Momelotinib
-
Stanford, California
- +5 more
Jan 31, 2019